Nuclear Medicine and Diagnostic Imaging (NMDI)
This mission of the Section of Nuclear Medicine and Diagnostic Imaging of the Division of Human Health emerges from the Article II of the Statutes: “The Agency shall seek to accelerate and enlarge the contribution of atomic energy to peace, health and prosperity throughout the world”. It has the specific mission of fostering the application of nuclear medicine techniques as part of the clinical management of certain types of diseases.
The long term objective of the subprogram in Nuclear Medicine focuses on enhancing Member States’ capability to address health needs by the use Nuclear Medicine techniques in both imaging and therapeutic applications, complementary to conventional techniques.
Different activities are run under this subprogram: Coordinated Research Projects (CRPs); Expert Meetings to advise the Agency on specific topics; Publications and Manuals, including educational material, and creation of educational website and databases. Many projects run under Nuclear Medicine have been clearly oriented towards the clinical applications of standard and emerging technologies in Nuclear Medicine such as SPECT/CT, PET/CT for diseases related to two of the major causes of death: cancer and cardiovascular diseases. Focus is also given to therapeutic applications wherein the primary objective is to make available fundamental radiopharmaceuticals for routine clinical use in developing countries, and to develop, evaluate and standardize new diagnostic and therapeutic radiopharmaceuticals for the effective use in diagnostic and therapeutic nuclear medicine procedures. Finally, the section manages projects related to quality improvement in the clinical practice of nuclear medicine.
Positron emission tomography (PET/CT)
Advances in Nuclear Cardiology